Firefly Neuroscience, Inc. (AIFF) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Firefly Neuroscience, Inc. stock (AIFF) is currently trading at $1.68. Firefly Neuroscience, Inc. PS ratio (Price-to-Sales) is 30.71. WallStSmart rates AIFF as Sell.
- AIFF PE ratio analysis and historical PE chart
- AIFF PS ratio (Price-to-Sales) history and trend
- AIFF intrinsic value — DCF, Graham Number, EPV models
- AIFF stock price prediction 2025 2026 2027 2028 2029 2030
- AIFF fair value vs current price
- AIFF insider transactions and insider buying
- Is AIFF undervalued or overvalued?
- Firefly Neuroscience, Inc. financial analysis — revenue, earnings, cash flow
- AIFF Piotroski F-Score and Altman Z-Score
- AIFF analyst price target and Smart Rating
Firefly Neuroscience, Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
Firefly Neuroscience, Inc. (AIFF) · 7 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in revenue growth. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Firefly Neuroscience, Inc. (AIFF) Key Strengths (1)
Revenue surging 1076.00% year-over-year
Firefly Neuroscience, Inc. (AIFF) Areas to Watch (6)
Company is destroying shareholder value
Losing money on operations
Very expensive at 30.7x annual revenue
Very low institutional interest at 5.96%
Micro-cap company with very limited liquidity and high volatility
Fairly priced relative to book value
Supporting Valuation Data
Firefly Neuroscience, Inc. (AIFF) Detailed Analysis Report
Overall Assessment
This company scores 24/100 in our Smart Analysis, earning a F grade. Out of 7 metrics analyzed, 1 register as strengths (avg 10.0/10) while 6 fall into concern territory (avg 2.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Revenue Growth. Growth metrics are encouraging with Revenue Growth at 1076.00%.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Price/Sales. Some valuation metrics including Price/Sales (30.71), Price/Book (2.49) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -340.80%, Operating Margin at -632.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -340.80% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 1076.00% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
AIFF Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
AIFF's Price-to-Sales ratio of 30.71x trades at a deep discount to its historical average of 362.79x (22th percentile). The current valuation is 99% below its historical high of 2332x set in Mar 2022, and 1975% above its historical low of 1.48x in Dec 2020. Over the past 12 months, the PS ratio has compressed from ~540.9x as trailing revenue scaled faster than the stock price.
Compare AIFF with Competitors
Top SOFTWARE - APPLICATION stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Firefly Neuroscience, Inc. (AIFF) · TECHNOLOGY › SOFTWARE - APPLICATION
The Big Picture
Firefly Neuroscience, Inc. is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 783,000 with 1076% growth year-over-year.
Key Findings
Revenue growing at 1076% YoY, reaching 783,000. This pace significantly outperforms most SOFTWARE - APPLICATION peers.
Spending 48% of revenue (378,000) on R&D, reinforcing its commitment to innovation and future growth.
Free cash flow is -2M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Growth sustainability: can Firefly Neuroscience, Inc. maintain 1076%+ revenue growth, or will competition slow it down?
Sector dynamics: monitor SOFTWARE - APPLICATION industry trends, competitive moves, and regulatory changes that could impact Firefly Neuroscience, Inc..
Bottom Line
Firefly Neuroscience, Inc. is a high-conviction growth story with revenue accelerating at 1076% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin 0.0% margins and premium valuation suggest patience until the unit economics mature further.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Firefly Neuroscience, Inc.(AIFF)
NASDAQ
TECHNOLOGY
SOFTWARE - APPLICATION
USA
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company is headquartered in Toronto, Canada.